UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

Comparative Pro-cognitive and Neurochemical Profiles of Glycine Modulatory Site Agonists and Glycine Reuptake Inhibitors in the Rat: Potential Relevance to Cognitive Dysfunction and Its Management

Molecular neurobiology, 2020-05, Vol.57 (5), p.2144-2166

2020

Volltextzugriff (PDF)

S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: III. Actions in models of therapeutic activity and induction of side effects

The Journal of pharmacology and experimental therapeutics, 2008-03, Vol.324 (3), p.1212

2008

Volltextzugriff (PDF)

S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine

The Journal of pharmacology and experimental therapeutics, 2001-08, Vol.298 (2), p.581

2001

Volltextzugriff (PDF)

The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis

The Journal of pharmacology and experimental therapeutics, 2004-10, Vol.311 (1), p.190

2004

Volltextzugriff (PDF)

Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex

Psychopharmacologia, 2008, Vol.196 (1), p.93-104

2008

Volltextzugriff (PDF)

Dual-acting agents for improving cognition and real-world function in Alzheimer’s disease: Focus on 5-HT6 and D3 receptors as hubs

Neuropharmacology, 2020-10, Vol.177, p.108099-108099, Article 108099

2020

Volltextzugriff (PDF)

Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade

Psychopharmacologia, 2005-02, Vol.177 (4), p.448-458

2005

Volltextzugriff (PDF)

5‐HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia

EMBO molecular medicine, 2012-10, Vol.4 (10), p.1043-1056

2012

Volltextzugriff (PDF)

S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo

The Journal of pharmacology and experimental therapeutics, 2008-02, Vol.324 (2), p.600

2008

Volltextzugriff (PDF)

Screening of compounds that alter sleep–wake state in zebrafish

Toxicology letters, 2014-09, Vol.229, p.S40-S40

2014

Volltextzugriff (PDF)

Selective blockade of dopamine D 3 versus D 2 receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis

Journal of neurochemistry, 2007-02, Vol.100 (4), p.1047-1061

2007

Volltextzugriff (PDF)

Selective blockade of dopamine D₃ versus D₂ receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis

Journal of neurochemistry, 2007-02, Vol.100 (4), p.1047-1061

2007

Volltextzugriff (PDF)

Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats : a pharmacological characterization: Special Issue on Drug Discrimination

Psychopharmacologia, 2009, Vol.203 (2), p.329-341

2009

Volltextzugriff (PDF)

S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models

Psychopharmacologia, 2008-09, Vol.199 (4), p.549-568

2008

Volltextzugriff (PDF)

S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole

The Journal of pharmacology and experimental therapeutics, 2004-06, Vol.309 (3), p.936

2004

Volltextzugriff (PDF)

Discriminative stimulus properties of the “atypical” antidepressant, mirtazapine, in rats: a pharmacological characterization

Psychopharmacology, 2009-04, Vol.203 (2), p.329-341

2009

Volltextzugriff (PDF)

Agomelatine suppresses locomotor hyperactivity in olfactory bulbectomised rats: A comparison to melatonin and to the 5-HT2c antagonist, S32006

European journal of pharmacology, 2012-01, Vol.674 (1), p.27-32

2012

Volltextzugriff (PDF)

S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization

The Journal of pharmacology and experimental therapeutics, 2012-03, Vol.340 (3), p.765

2012

Volltextzugriff (PDF)

Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake: A pharmacological characterization of diverse classes of antidepressant agents

Pharmacology, biochemistry and behavior, 2002-04, Vol.71 (4), p.667-680

2002

Volltextzugriff (PDF)

Discriminative stimulus properties of the selective and highly potent α2-adrenoceptor agonist, S18616, in rats: Mediation by the α2A subtype, and blockade by the atypical antidepressants, mirtazapine and mianserin

Neuropharmacology, 2006-09, Vol.51 (4), p.718-726

2006

Volltextzugriff (PDF)

Behavioural Models for the Characterisation of Established and Innovative Antidepressant Agents

Therapie, 2005-09, Vol.60 (5), p.477-484

Dekeyne, Anne

2005

Volltextzugriff (PDF)

Activation of dopamine D1 receptors enhances cholinergic transmission and social cognition: a parallel dialysis and behavioural study in rats

The international journal of neuropsychopharmacology, 2007-06, Vol.10 (3), p.383-399

2007

Volltextzugriff (PDF)

Neurokinin Antagonists Potentiate Antidepressant Properties of Serotonin Reuptake Inhibitors, Yet Blunt Their Anxiogenic Actions: A Neurochemical, Electrophysiological, and Behavioral Characterization

Neuropsychopharmacology (New York, N.Y.), 2009-03, Vol.34 (4), p.1039-1056

2009

Volltextzugriff (PDF)

Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake

Pharmacology, biochemistry and behavior, 2002-04, Vol.71 (4), p.667-680

2002

Volltextzugriff (PDF)

Behavioural Models for the Characterisation of Established and Innovative Antidepressant Agents

Therapie, 2005-09, Vol.60 (5), p.477-484

Dekeyne, Anne

2005

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(75)

Sprache

Erscheinungsjahr

n.n

Thema

Animals
(36)
Rats
(35)
Male
(30)
Rats, Wistar
(28)
Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Pharmacology & Pharmacy
(21)
Biological And Medical Sciences
(20)
Antidepressant
(17)
Dose-Response Relationship, Drug
(17)
Neurosciences
(17)
Neurosciences & Neurology
(17)
Medical Sciences
(16)
Psychology. Psychoanalysis. Psychiatry
(16)
Mice
(15)
Pharmacology. Drug Treatments
(15)
Psychiatry
(15)
Neuropharmacology
(14)
Psychopharmacology
(14)
Behavior, Animal - Drug Effects
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparative Pro-cognitive and Neurochemical Profiles of Glycine Modulatory Site Agonists and Glycine Reuptake Inhibitors in the Rat: Potential Relevance to Cognitive Dysfunction and Its Management

S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: III. Actions in models of therapeutic activity and induction of side effects

S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine

The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis

Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex

Dual-acting agents for improving cognition and real-world function in Alzheimer’s disease: Focus on 5-HT6 and D3 receptors as hubs

Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade

5‐HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia

S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo

Screening of compounds that alter sleep–wake state in zebrafish

Selective blockade of dopamine D 3 versus D 2 receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis

Selective blockade of dopamine D₃ versus D₂ receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis

Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats : a pharmacological characterization: Special Issue on Drug Discrimination

S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models

S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole

Discriminative stimulus properties of the “atypical” antidepressant, mirtazapine, in rats: a pharmacological characterization

Agomelatine suppresses locomotor hyperactivity in olfactory bulbectomised rats: A comparison to melatonin and to the 5-HT2c antagonist, S32006

S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization

Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake: A pharmacological characterization of diverse classes of antidepressant agents

Discriminative stimulus properties of the selective and highly potent α2-adrenoceptor agonist, S18616, in rats: Mediation by the α2A subtype, and blockade by the atypical antidepressants, mirtazapine and mianserin

Behavioural Models for the Characterisation of Established and Innovative Antidepressant Agents

Activation of dopamine D1 receptors enhances cholinergic transmission and social cognition: a parallel dialysis and behavioural study in rats

Neurokinin Antagonists Potentiate Antidepressant Properties of Serotonin Reuptake Inhibitors, Yet Blunt Their Anxiogenic Actions: A Neurochemical, Electrophysiological, and Behavioral Characterization

Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake

Behavioural Models for the Characterisation of Established and Innovative Antidepressant Agents

Suchergebnisse filtern